174 related articles for article (PubMed ID: 18499731)
1. Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma.
Margetts CD; Morris M; Astuti D; Gentle DC; Cascon A; McRonald FE; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
Endocr Relat Cancer; 2008 Sep; 15(3):777-86. PubMed ID: 18499731
[TBL] [Abstract][Full Text] [Related]
2. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma.
Astuti D; Morris M; Krona C; Abel F; Gentle D; Martinsson T; Kogner P; Neumann HP; Voutilainen R; Eng C; Rustin P; Latif F; Maher ER
Br J Cancer; 2004 Nov; 91(10):1835-41. PubMed ID: 15505628
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.
Margetts CD; Astuti D; Gentle DC; Cooper WN; Cascon A; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
Endocr Relat Cancer; 2005 Mar; 12(1):161-72. PubMed ID: 15788647
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
[TBL] [Abstract][Full Text] [Related]
6. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
[TBL] [Abstract][Full Text] [Related]
8. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Clarke N; Brown M; Kishida T; Yao M; Teh BT; Latif F; Maher ER
Br J Cancer; 2008 Jan; 98(2):496-501. PubMed ID: 18195710
[TBL] [Abstract][Full Text] [Related]
9. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
Woodward ER; Eng C; McMahon R; Voutilainen R; Affara NA; Ponder BA; Maher ER
Hum Mol Genet; 1997 Jul; 6(7):1051-6. PubMed ID: 9215674
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
[TBL] [Abstract][Full Text] [Related]
11. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.
Morris MR; Ricketts C; Gentle D; Abdulrahman M; Clarke N; Brown M; Kishida T; Yao M; Latif F; Maher ER
Oncogene; 2010 Apr; 29(14):2104-17. PubMed ID: 20154727
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide.
Chatzikyriakou P; Brempou D; Quinn M; Fishbein L; Noberini R; Anastopoulos IN; Tufton N; Lim ES; Obholzer R; Hubbard JG; Moonim M; Bonaldi T; Nathanson KL; Izatt L; Oakey RJ
Clin Epigenetics; 2023 Dec; 15(1):196. PubMed ID: 38124114
[TBL] [Abstract][Full Text] [Related]
13. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma.
Alaminos M; Davalos V; Cheung NK; Gerald WL; Esteller M
J Natl Cancer Inst; 2004 Aug; 96(16):1208-19. PubMed ID: 15316056
[TBL] [Abstract][Full Text] [Related]
14. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
15. Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas.
Kiss NB; Kogner P; Johnsen JI; Martinsson T; Larsson C; Geli J
BMC Med Genet; 2012 Sep; 13():83. PubMed ID: 22984959
[TBL] [Abstract][Full Text] [Related]
16. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
[TBL] [Abstract][Full Text] [Related]
17. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
[TBL] [Abstract][Full Text] [Related]
18. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
[TBL] [Abstract][Full Text] [Related]
19. The genomic landscape of phaeochromocytoma.
Flynn A; Benn D; Clifton-Bligh R; Robinson B; Trainer AH; James P; Hogg A; Waldeck K; George J; Li J; Fox SB; Gill AJ; McArthur G; Hicks RJ; Tothill RW
J Pathol; 2015 May; 236(1):78-89. PubMed ID: 25545346
[TBL] [Abstract][Full Text] [Related]
20. Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma.
Carén H; Djos A; Nethander M; Sjöberg RM; Kogner P; Enström C; Nilsson S; Martinsson T
BMC Cancer; 2011 Feb; 11():66. PubMed ID: 21314941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
